Antimicrobial therapy and late onset sepsis

NeoReviews

Volumn 13, Issue 2, 2012, Pages

  Chu, Alison ^a   Hageman, Joseph R ^b,c   Schreiber, Michael ^d   Alexander, Kenneth ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861409531     PISSN: None     EISSN: 15269906     Source Type: Journal    
DOI: 10.1542/neo.13-2-e94     Document Type: Article

References (33)

1. Higgins RD, Baker CJ, Raju TN. Executive summary of the workshop on infection in the high-risk infant. J Perinatol. 2010;30 (6):379-383
2. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2 pt 1):285-291
3. Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed. 2011;96(1):F9-F14
4. Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventyfive years of neonatal sepsis at Yale: 1928-2003. Pediatrics. 2005; 116(3):595-602
5. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics. 2002;109(1):34-39
6. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birth weight infants. Am J Obstet Gynecol. 2007;196:147.e1-147.e8
7. Samanta S, Farrer K, Breathnach A, Heath PT. Risk factors for late onset Gram-negative infections: a case-control study. Arch Dis Child Fetal Neonatal Ed. 2011;96(1):F15-F18
8. Shetty SS, Harrison LH, Hajjeh RA, et al. Determining risk factors for candidemia among newborn infants from populationbased surveillance: Baltimore, Maryland, 1998-2000. Pediatr Infect Dis J. 2005;24(7):601-604
9. Bizzarro MJ, Jiang Y, Hussain N, Gruen JR, Bhandari V, Zhang H. The impact of environmental and genetic factors on neonatal lateonset sepsis. J Pediatr. 2011;158(2):234-238, e1
10. Downey LC, Smith PB, Benjamin DK Jr. Risk factors and prevention of late-onset sepsis in premature infants. Early Hum Dev. 2010;86(suppl 1):7-12
11. Zaidi AKM, Harrell LJ, Rost JR, Reller LB. Assessment of similarity among coagulase-negative staphylococci from sequential blood cultures of neonates and children by pulsed-field gel electrophoresis. J Infect Dis. 1996;174(5):1010-1014
12. Vermont Oxford Database Manual of Operations. Release 2.0. Burlington, VT: Vermont Oxford Network; 1993
13. Jean-Baptiste N, Benjamin DK Jr, Cohen-Wolkowiez M, et al. Coagulase-negative staphylococcal infections in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2011;32(7): 679-686
14. Lessa FC, Edwards JR, Fridkin SK, Tenover FC, Horan TC, Gorwitz RJ. Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004. Pediatr Infect Dis J. 2009;28(7):577-581
15. Rubin LG, Sánchez PJ, Siegel J, Levine G, Saiman L, Jarvis WR; Pediatric Prevention Network. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics. 2002;110(4):e42-e49
16. Sarkar S, Bhagat I, DeCristofaro JD, Wiswell TE, Spitzer AR. A study of the role of multiple site blood cultures in the evaluation of neonatal sepsis. J Perinatol. 2006;26(1):18-22
17. Flidel-Rimon O, Leibovitz E, Eventov Friedman S, Juster- Reicher A, Shinwell ES. Is lumbar puncture (LP) required in every workup for suspected late-onset sepsis in neonates? Acta Paediatr. 2011;100(2):303-304
18. Kuppala VS, Meinzen-Derr J, Morrow AL, Schibler KR. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr. 2011;159(5): 720-725
19. Gordon A, Jeffery HE. Antibiotic regimens for suspected lateonset sepsis in newborn infants. Cochrane Database Syst Rev.2005; (3):CD004501
20. Malik RK, Montecalvo MA, Reale MR, et al. Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit. Pediatr Infect Dis J. 1999;18(4):352-356
21. Isaacs D. Rationing antibiotic use in neonatal units. Arch Dis Child Fetal Neonatal Ed. 2000;82(1):F1-F2
22. Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics. 2000;106(6): 1387-1390
23. Chiu CH, Michelow IC, Cronin J, Ringer SA, Ferris TG, Puopolo KM. Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit. Pediatr Infect Dis J. 2011;30(4): 273-278
24. Stoll BJ, Hansen NI, Adams-Chapman I, et al; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292(19):2357-2365
25. Muller-Pebody B, Johnson AP, Heath PT, Gilbert RE, Henderson KL, Sharland M; iCAP Group (Improving Antibiotic Prescribing in Primary Care). Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal7 Neonatal Ed. 2011;96(1):F4-F8
26. Zaoutis T, Walsh TJ. Antifungal therapy for neonatal candidiasis. Curr Opin Infect Dis. 2007;20(6):592-597
27. Kaiser JR, Cassat JE, Lewno MJ. Should antibiotics be discontinued at 48 hours for negative late-onset sepsis evaluations in the neonatal intensive care unit? J Perinatol. 2002;22(6):445-447
28. Guerti K, Devos H, Ieven MM, Mahieu LM. Time to positivity of neonatal blood cultures: fast and furious? J Med Microbiol. 2011; 60(Pt 4):446-453
29. Patel SJ, Oshodi A, Prasad P, et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance. Pediatr Infect Dis J. 2009;28(12):1047-1051
30. Pessoa-Silva CL, Hugonnet S, Pfister R, et al. Reduction of health care associated infection risk in neonates by successful hand hygiene promotion. Pediatrics. 2007;120(2):e382-e390
31. Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics. 2005;116(2):e198-e205
32. Bell SG. Vancomycin prophylaxis for late-onset sepsis in very low and extremely low birth weight neonates. Neonatal Netw. 2008;27(5):351-354
33. Brocklehurst P, Farrell B, King A, et al; INIS Collaborative Group. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med. 2011;365(13):1201-1211